US20180369158A1 - Nucleic acid nanocapsules for drug delivery and targeted gene knockdown - Google Patents

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown Download PDF

Info

Publication number
US20180369158A1
US20180369158A1 US16/016,511 US201816016511A US2018369158A1 US 20180369158 A1 US20180369158 A1 US 20180369158A1 US 201816016511 A US201816016511 A US 201816016511A US 2018369158 A1 US2018369158 A1 US 2018369158A1
Authority
US
United States
Prior art keywords
nans
dnazyme
nucleic acid
agent
multifunctional nanoparticle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US16/016,511
Other versions
US10780058B2 (en
Inventor
Jessica Lynn ROUGE
Joseph Awino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Connecticut
Original Assignee
University of Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201762523929P priority Critical
Application filed by University of Connecticut filed Critical University of Connecticut
Priority to US16/016,511 priority patent/US10780058B2/en
Assigned to UNIVERSITY OF CONNECTICUT reassignment UNIVERSITY OF CONNECTICUT ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ROUGE, JESSICA LYNN, AWINO, Joseph
Publication of US20180369158A1 publication Critical patent/US20180369158A1/en
Application granted granted Critical
Publication of US10780058B2 publication Critical patent/US10780058B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links